Characterization of the neoplastic phenotype in the familial atypical multiple-mole melanoma-pancreatic carcinoma syndrome
- PMID: 12910525
- DOI: 10.1002/cncr.11562
Characterization of the neoplastic phenotype in the familial atypical multiple-mole melanoma-pancreatic carcinoma syndrome
Abstract
Background: Previous studies suggest that the familial atypical multiple-mole melanoma (FAMMM) syndrome may predispose affected families to nonmelanoma carcinomas, including adenocarcinoma of the pancreas. It has been found that many of these families harbor mutations in the CDKN2A gene on chromosome 9p21. The phenotypic expression of CDKN2A mutations in these families has not been characterized fully.
Methods: The authors studied eight families that appeared to inherit multiple nevi, cutaneous melanomas, and pancreatic carcinomas in association with a CDKN2A germline mutation. The expression of disease within these families was examined, and segregation ratios were estimated to assess the patterns of inheritance according to various definitions of phenotype.
Results: Either multiple nevi or pancreatic carcinoma was diagnosed in 53% of first-degree relatives of the probands. The offspring of parents affected with multiple nevi, melanoma, or pancreatic carcinoma were significantly more likely to be affected themselves compared with the offspring of unaffected parents (48.9% vs. 16.7%; P = 0.004).
Conclusions: The current results provide additional evidence that multiple nevi, melanoma, or pancreatic carcinoma may be inherited as autosomal-dominant traits in families known to harbor CDKN2A mutations. Other malignancies may be a part of the phenotype in these families, although this hypothesis requires additional study.
Copyright 2003 American Cancer Society.DOI 10.1002/cncr.11562
Similar articles
-
Clinical and genetic analysis of 18 pancreatic carcinoma/melanoma-prone families.Clin Genet. 2010 Apr;77(4):333-41. doi: 10.1111/j.1399-0004.2009.01352.x. Epub 2009 Dec 22. Clin Genet. 2010. PMID: 20041885
-
Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome.Cancer. 2002 Jan 1;94(1):84-96. doi: 10.1002/cncr.10159. Cancer. 2002. PMID: 11815963
-
Multiple primary melanoma revisited.Cancer. 2002 Apr 15;94(8):2248-55. doi: 10.1002/cncr.10454. Cancer. 2002. PMID: 12001124
-
[From gene to disease; from p16 to melanoma].Ned Tijdschr Geneeskd. 2000 Oct 28;144(44):2100-2. Ned Tijdschr Geneeskd. 2000. PMID: 11103670 Review. Dutch.
-
Hereditary cancer syndrome diagnosis: molecular genetic clues and cancer control.Future Oncol. 2007 Apr;3(2):169-81. doi: 10.2217/14796694.3.2.169. Future Oncol. 2007. PMID: 17381417 Review.
Cited by
-
Pancreatic Tumorigenesis: Precursors, Genetic Risk Factors and Screening.Curr Oncol. 2022 Nov 15;29(11):8693-8719. doi: 10.3390/curroncol29110686. Curr Oncol. 2022. PMID: 36421339 Free PMC article. Review.
-
Cutaneous Manifestations in Pancreatic Diseases-A Review.J Clin Med. 2020 Aug 12;9(8):2611. doi: 10.3390/jcm9082611. J Clin Med. 2020. PMID: 32806580 Free PMC article. Review.
-
Management strategies for patients with hereditary pancreatic cancer.Curr Treat Options Oncol. 2005 Sep;6(5):437-45. doi: 10.1007/s11864-005-0046-6. Curr Treat Options Oncol. 2005. PMID: 16107246 Review.
-
Effect of a detailed family history of melanoma on risk for other tumors: a cohort study based on the nationwide Swedish Family-Cancer Database.J Invest Dermatol. 2014 Apr;134(4):930-936. doi: 10.1038/jid.2013.460. Epub 2013 Nov 5. J Invest Dermatol. 2014. PMID: 24192716
-
Molecular markers of tumor progression in melanoma.Curr Genomics. 2009 Jun;10(4):231-9. doi: 10.2174/138920209788488526. Curr Genomics. 2009. PMID: 19949544 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous